中医药治疗脓毒症心肌损伤的研究进展
刘洋;梁群;李鹤然;刘雨默;于佳琪;
摘要(Abstract):
脓毒症是严重创伤、感染、休克及大手术后常见的并发症,具有发病率高、病死率高及住院费用高的特点,而脓毒症心肌损伤是脓毒症患者死亡的主要原因之一。该文就脓毒症心肌损伤的中医治疗研究进展进行综述,包括单味中药及其有效提取物、中药汤剂、中药制剂、针灸等方面,旨在为脓毒症心肌损伤的诊治提供参考。
关键词(KeyWords): 脓毒症;心肌损伤;中医药;治疗;综述
基金项目(Foundation): 国家自然科学基金面上项目(81974557);; 黑龙江中医药大学“双一流”中西医结合学科发展助力基金(051022)
作者(Authors): 刘洋;梁群;李鹤然;刘雨默;于佳琪;
参考文献(References):
- [1] Singer M,Deutschman CS,Seymour CW,et al. The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J]. Jama,2016,315(8):801-810.
- [2] Léger T,Charrier A,Moreau C,et al. Early sepsis does not stimulate reactive oxygen species production and does not reduce cardiac function despite an increased inflammation status[J]. Physiological reports,2017,5(13):13231.
- [3] Beesley SJ,Weber G,Sarge T,et al. Septic cardiomyopathy[J]. Critical care medicine,2018,46(4):625-634.
- [4] Minasyan H. Sepsis and septic shock:Pathogenesis and treatment perspectives[J]. Journal of Critical Care,2017,8(40):229-242.
- [5] Zheng Z,Ma H,Zhang X,et al. Enhanced glycolytic metabolism contributes to cardiac dysfunction in polymicrobial sepsis[J]. The Journal of Infectious Diseases,2017,215(9):1396-1406.
- [6]赵红芳,江其敏,刘清泉.刘清泉教授应用中医药治疗脓毒症的临床经验[J].中国中医急症,2017,26(9):1563-1565.
- [7]王今达,李志军,李银平.从“三证三法”辨证论治脓毒症[J].中国危重病急救医学,2006,18(11):643-644.
- [8]邓兆岿,阚诗云,邱占军.中医药治疗脓毒症心肌损伤的研究进展[J].中国中医急症,2018,27(7):1296-1299.
- [9]张云松,朱晓林.脓毒症中医病机及治法探讨[J].上海中医药杂志,2012,46(10):8-9.
- [10]李志军,李银平.王今达教授“菌毒炎并治”脓毒症的实验基础与临床实践总结[J].中华危重病急救医学,2017,29(12):1062-1064.
- [11]石玉君.脓毒症心肌损伤的证素证型分布规律及其相关因素的临床研究[D].北京:中国中医科学院,2017.
- [12] Tung CL,Ju DT,Velmurugan BK,et al. Carthamus tinctorius L. extract activates insulin-like growth factor-I receptor signaling to inhibit FAS-death receptor pathway and suppress lipopolysaccharides-induced H9c2 cardiomyoblast cell apoptosis[J]. Environmental toxicology,2019,34(12):1320-1328.
- [13] Sun B,Xiao J,Sun XB,et al. Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice:an insight into oestrogen receptor activation and PI3K/Akt signalling[J]. British Journal of Pharmacology,2013,168(7):1758-1770.
- [14] Ma S,Wang X,Wang Y,et al. Sodium tanshinoneⅡA sulfonate ismproves hemodynamic parameters,Cytokine release,and multi-organ damage in endotoxemia rabbits[J]. Medical science monitor:international medical journal of experimental and clinical research,2018,24:2975-2982.
- [15] Chen RC,Wang J,Yang L,et al. Protective effects of ginsenoside Re on lipopolysaccharide-induced cardiac dysfunction in mice[J]. Food&function,2016,7(5):2278-2287.
- [16]刘文军,薛燕星,胡东鹏.升降散的现代药理机制研究进展[J].北京中医药,2012,31(12):939-943.
- [17]赵雷,钱风华,丁纯蕾,等.升降散对脓毒症大鼠心肌p38~(MAPK)蛋白磷酸化水平的影响[J].中国临床医学,2017,24(1):6-11.
- [18]钱风华,赵雷,沈梦雯,等.升降散改善脓毒症大鼠心肌损伤的机制研究[J].辽宁中医杂志,2017,44(4):845-848,897.
- [19]王宸罡,齐新,王丽,等.简述黄连解毒汤的药理作用及临床应用[J].天津中医药大学学报,2018,37(5):433-436.
- [20]高洁,孔祥英.黄连解毒汤治疗脓毒症心肌损伤临床观察[J].世界最新医学信息文摘,2018,18(16):212.
- [21]石姗.黄连解毒汤防治脓毒症心肌损伤热毒内盛证的临床及实验研究[D].济南:山东中医药大学,2019.
- [22]杨占达,董桂英,赵文华.血府逐瘀汤药理作用及临床应用研究进展[J].实用中医药杂志,2017,33(9):1106-1108.
- [23] Meng F,Lai H,Luo Z,et al. Effect of Xuefu Zhuyu Decoction pretreatment on myocardium in sepsis rats[J]. Evidencebased complementary and alternative medicine:eCAM,2018,2018:2939307.
- [24]廖云海,卢静,王志民,等.血必净注射液对脓毒症心肌保护的临床研究[J].中国医药科学,2020,10(22):55-57.
- [25]张宏伟,魏立友,赵刚,等.血必净注射液对老年脓毒症患者心肌损伤的保护作用[J].中国老年学杂志,2017,37(19):4863-4865.
- [26]沈琪琦,张之龄.参附注射液对脓毒症心肌损伤患者血浆BNP和炎性因子的影响[J].中国中医急症,2017,26(1):184-185,188.
- [27] Xu P,Zhang WQ,Xie J,et al. Shenfu injection prevents sepsis-induced myocardial injury by inhibiting mitochondrial apoptosis[J]. Journal of ethnopharmacology,2020,261:113068.
- [28]黄美红,黄可可,林茂恩,等.黄芪注射液治疗脓毒症心肌损伤疗效及护理观察[J].新中医,2015,47(4):301-302.
- [29]邵萍.黄芪注射液对脓毒症幼鼠心肌损伤的保护作用[D].南昌:南昌大学,2018.
- [30]胡丹丹,陈伟,孙鑫.醒脑静注射液调控NF-κB信号通路对脓毒症心肌损伤的影响[J].中国中医急症,2012,21(8):1260-1262.
- [31]王金华,车頔,陈东,等.醒脑静注射液对脓毒症大鼠心肌线粒体氧化应激损伤的作用[J].实用医学杂志,2015,31(9):1403-1406.
- [32]孙芳园,张纬,袁林,等.电针对脓毒症心肌损伤病人microRNA-133a表达影响[J].蚌埠医学院学报,2020,45(3):335-337,341.
- [33] Zhang L,Huang Z,Shi X,et al. Protective effect of electroacupuncture at zusanli on myocardial injury in septic rats[J]. Evidence-based complementary and alternative medicine:eCAM,2018,2018:6509650.